Songling Xuemaikang capsules for patients with low-to-medium risk hypertension: study protocol for a randomized controlled trial

BACKGROUND: Hypertension is a major risk factor for cardio-cerebrovascular disease. Songling Xuemaikang capsules (SXC), a formulation of Chinese herbal patent medicine, has been used as a complementary medicine with conventional western medicine to treat patients with hypertension since 1994 in main...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Trials
Main Authors: Jiang, Yuerong, Guo, Haiyan, Liu, Yue, Wang, Xin, Liang, Jiaqi, Xi, Ruixi, Bai, Ruina, Shi, Dazhuo
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2019
Teme:
Study Protocol
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6466697/
https://ncbi.nlm.nih.gov/pubmed/30987658
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-019-3308-5
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki